Clinical Study

An Open-Label, Multicenter Trial To Assess The Safety And Tolerability Of Lumateperone In The Treatment Of Pediatric Patients With Schizophrenia Or Bipolar Disorder

Posted Date: Jan 7, 2025

  • Investigator: Melissa Delbello
  • Specialties: Adolescent Psychiatry/Psychology, Bipolar Disorder, Psychiatry/Psychology
  • Type of Study: Drug

The purpose of this clinical research study is to look at how safe and tolerable an investigational study drug called lumateperone is and whether it works when given to adolescents with schizophrenia (13 to 17 years of age) or with bipolar disorder (10 to 17 years of age).

Criteria:

Null

Keywords:

Schizophrenia, Bipolar Disorder, Pediatric

For More Information:

Raechel Cooley
513 558-6205
cooleyra@uc.edu